Get started
Procter & Gamble Health Ltd.Procter & Gamble Health Ltd.Procter & Gamble Health Ltd.

Procter & Gamble Health Ltd.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪98.69 B‬ INR
Dividend yield (indicated)
1.53%
Price to earnings Ratio (TTM)
32.15
Basic EPS (TTM)
184.85 INR
Net income (FY)
‪3.13 B‬ INR
Revenue (FY)
‪12.45 B‬ INR
Shares float
‪7.94 M‬
Beta (1Y)
0.57

Employees


Employees (FY)
‪1.56 K‬
Change (1Y)
−43 −2.69%
Revenue / Employee (1Y)
‪8.00 M‬ INR
Net income / Employee (1Y)
‪2.01 M‬ INR

About Procter & Gamble Health Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Milind Thatte
Website
pghealthindia.com
Headquarters
Mumbai
Founded
1967
ISIN
INE199A01012
FIGI
BBG000CQR0Z0
Procter & Gamble Health Ltd. engages in the manufacture and marketing of pharmaceuticals products. It offers its products through the following brands: Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. It operates through India, and Outside India geographical segments. The company was founded in 1967 and is headquartered in Mumbai, India.

Check out other big names from the same industry as PGHL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs


SMIN
iShares MSCI India Small Cap ETF
Weight
0.12%
Market value
‪1.07 M‬
USD
EWX
SPDR S&P Emerging Markets Small Cap ETF
Weight
0.04%
Market value
‪342.66 K‬
USD
AVXC
Avantis Emerging Markets ex-China Equity ETF
Weight
0.02%
Market value
‪33.66 K‬
USD
AVEE
Avantis Emerging Markets Small Cap Equity ETF
Weight
0.05%
Market value
‪30.93 K‬
USD
MOHEALTH
Motilal Oswal S&P BSE Healthcare ETF
Weight
0.36%
Market value
‪14.45 K‬
USD
BSE500IETF
ICICI Prudential BSE 500 ETF
Weight
0.03%
Market value
‪9.24 K‬
USD
HDFCBSE500
HDFC S&P BSE 500 ETF
Weight
0.03%
Market value
551.50
USD

Explore more ETFs 

Frequently Asked Questions


The current price of PGHL is 5,806.60 INR — it has decreased by −0.98% in the past 24 hours. Watch Procter & Gamble Health Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange Procter & Gamble Health Ltd. stocks are traded under the ticker PGHL.
PGHL stock has fallen by −4.42% compared to the previous week, the month change is a −4.68% fall, over the last year Procter & Gamble Health Ltd. has showed a 8.13% increase.
PGHL reached its all-time high on Feb 11, 2021 with the price of 7,499.95 INR, and its all-time low was 260.00 INR and was reached on Oct 27, 2008. View more price dynamics on PGHL chart.
See other stocks reaching their highest and lowest prices.
PGHL stock is 3.44% volatile and has beta coefficient of 0.57. Track Procter & Gamble Health Ltd. stock price on the chart and check out the list of the most volatile stocks — is Procter & Gamble Health Ltd. there?
Today Procter & Gamble Health Ltd. has the market capitalization of ‪97.87 B‬, it has decreased by −0.72% over the last week.
Yes, you can track Procter & Gamble Health Ltd. financials in yearly and quarterly reports right on TradingView.
Procter & Gamble Health Ltd. is going to release the next earnings report on Apr 30, 2026. Keep track of upcoming events with our Earnings Calendar.
PGHL net income for the last quarter is ‪885.40 M‬ INR, while the quarter before that showed ‪661.80 M‬ INR of net income which accounts for 33.79% change. Track more Procter & Gamble Health Ltd. financial stats to get the full picture.
Procter & Gamble Health Ltd. dividend yield was 2.43% in 2024, and payout ratio reached 88.52%. The year before the numbers were 1.81% and 68.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2025, the company has ‪1.56 K‬ employees. See our rating of the largest employees — is Procter & Gamble Health Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Procter & Gamble Health Ltd. EBITDA is ‪4.15 B‬ INR, and current EBITDA margin is 34.72%. See more stats in Procter & Gamble Health Ltd. financial statements.
Like other stocks, PGHL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Procter & Gamble Health Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Procter & Gamble Health Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Procter & Gamble Health Ltd. stock shows the buy signal. See more of Procter & Gamble Health Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.